Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
CARPL.ai Raises $10M Led by IFC to Accelerate Healthcare AI Adoption Globally
CARPL.ai, the world’s largest radiology AI marketplace and enterprise platform, today announced a Series A round of USD $10 million led by International Finance Corporation (IFC), the private sector arm of the World Bank Group, with participation from Stellaris Venture Partners and other investors. The funding will accelerate CARPL’s mission to help healthcare providers adopt AI in a meaningful and safe manner.
CARPL is trusted by the world’s largest and most prestigious healthcare organizations, including four of the world’s top five private radiology groups. It is also being used by many governments, including Brazil, India, Singapore, Spain and the UAE.
Medical imaging generates more than 80% of healthcare data, as imaging demand continues to outpace radiologist capacity. Although more than 1,000 FDA-cleared radiology AI applications are available today, adoption remains fragmented. Healthcare organizations are forced to evaluate, integrate, and monitor dozens of standalone AI products independently, creating significant operational and IT complexity. In short, while the AI applications exist, the governance of these applications does not.
Through a single integration with CARPL, healthcare providers gain access to the world’s largest radiology AI marketplace with more than 300 AI applications from over 100 partners. In addition to this, the CARPL platform also enables its customers to build, test, deploy, and monitor AI across clinical workflows while remaining vendor-neutral and infrastructure-agnostic.
The investment will support continued product innovation, expansion of CARPL’s global partner ecosystem, and commercial growth across North America, LATAM, Europe, Asia-Pacific, and emerging markets. The partnership also reflects a shared focus on advancing digital health innovation through CARPL’s model of building high-skill engineering, product development, and AI capabilities in India for deployment to healthcare providers around the world.
“Our mission is to ensure that clinicians can confidently utilize the absolute best AI technology available for their patients. Over the past few years, we have built…
Full release here, originally announced July 23rd, 2026.
Pearl Health Raises $110 Million to Expand Its AI Platform Helping Providers Deliver Better Outcomes at Lower Cost for Medicare Patients
The Company Reached Profitability in 2025 and is Projected to Generate $500 Million in Gross Healthcare System Savings While Tripling Its Patient Base from 2024 Through the End of 2026
Pearl Health, a healthcare technology company helping manage risk and deliver better care to Medicare patients, today announced a $110 million capital raise, comprised of equity investment led by Andreessen Horowitz with participation from Viking Global Investors, AlleyCorp, Ulysses Capital, and a debt facility led by Trinity Capital. The new capital will expand Pearl’s AI platform, turning clinical intelligence into measurable outcomes, and accelerate its growth across enterprise health system and payer partnerships, its expansion into Medicare Advantage, and new risk offerings.
More than 70 million people today rely on Medicare, with costs exceeding $1 trillion and climbing. Across healthcare, reimbursement is increasingly tied to outcomes rather than utilization, creating powerful incentives for providers to prevent avoidable illness, intervene earlier, and manage patient populations. As healthcare shifts from reactive treatment to preventative care, demand is accelerating for technologies that enable providers to succeed in this new model.
“Pearl was founded on a simple belief: healthcare should reward keeping people healthy, not just treating them when they are sick,” said Michael Kopko, Co-Founder and CEO at Pearl Health. “Unnecessary costs and poor outcomes persist in US healthcare because most providers lack the capabilities to shift to outcomes-based care alone. With this financing, we are investing in accelerated innovation and growth to expand our impact across the healthcare system.”
“Pearl has demonstrated that managing risk across large patient populations across many different settings of care can improve patient outcomes, generate meaningful savings, and support a sustainable business model at scale,” said Vineeta Agarwala, MD, General Partner at Andreessen Horowitz. “Pearl’s ability to enable providers to participate in value-based payment programs successfully – and to do so through technology, rather than clinical workforce expansion – is a testament to both the vision and execution of the Pearl team.”
“We believe Pearl Health is changing how providers participate in value-based care, simplifying the data and daily workflow so they can spend more of their time and attention on their patients,” said Phil Gager, Senior Managing Director, Tech Lending at Trinity Capital…
Full release here, originally announced July 8th, 2026.
No comments:
Post a Comment